Amer Journal-Indl Medicine is categorized under Periodical Publishers in Hoboken, NJ .
Amer Journal-Indl Medicine was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Periodical Publishers business, which does work in the B2B market, and is classified as a Periodical Publishers, under code number 5111200 by the NAICS.
If you are seeking more information, feel free to contact Kim Thompkins, Manager at the company’s single location by writing to 111 River St, Hoboken, New Jersey NJ 07030 or by phoning (201) 748-6000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Amer Journal-Indl Medicine |
| Contact Person: | Kim Thompkins, Manager |
| Address: | 111 River St, Hoboken, New Jersey 07030 |
| Phone Number: | (201) 748-6000 |
| Website Address: | wiley.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Periodical Publishers |
| SIC Code: | 2721 |
| NAICS Code: | 5111200 |
| Share This Business: |
Amer Journal-Indl Medicine was started in 0 to provide professional Periodical Publishers under the SIC code 2721 and NAICS code 5111200. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Kim Thompkins, Manager for inquiries that concern Amer Journal-Indl Medicine by calling the company number (201) 748-6000, as your correspondence is most welcome. Additionally, the physical location of the single location of Amer Journal-Indl Medicine can be found at the coordinates 40.737232,-74.028714 as well as the street address 111 River St in Hoboken, New Jersey 07030.
For its online presence, you may visit Amer Journal-Indl Medicine’s website at wiley.com and engage with its social media outlets through on Twitter and on Facebook.